1. Home
  2. IMXI vs OMER Comparison

IMXI vs OMER Comparison

Compare IMXI & OMER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International Money Express Inc.

IMXI

International Money Express Inc.

HOLD

Current Price

$14.47

Market Cap

469.3M

Sector

Technology

ML Signal

HOLD

Logo Omeros Corporation

OMER

Omeros Corporation

HOLD

Current Price

$17.33

Market Cap

844.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMXI
OMER
Founded
1994
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
469.3M
844.6M
IPO Year
2016
2008

Fundamental Metrics

Financial Performance
Metric
IMXI
OMER
Price
$14.47
$17.33
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$15.00
$32.50
AVG Volume (30 Days)
424.4K
2.0M
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
98.15
EPS
0.15
0.77
Revenue
$319,601,000.00
$29,868,000.00
Revenue This Year
$0.83
N/A
Revenue Next Year
$1.49
$233.22
P/E Ratio
$78.00
$22.49
Revenue Growth
16.68
N/A
52 Week Low
$11.15
$3.94
52 Week High
$15.95
$18.14

Technical Indicators

Market Signals
Indicator
IMXI
OMER
Relative Strength Index (RSI) 64.07 83.27
Support Level $13.29 $9.12
Resistance Level $15.49 $17.65
Average True Range (ATR) 0.58 0.75
MACD 0.14 0.52
Stochastic Oscillator 97.08 87.76

Price Performance

Historical Comparison
IMXI
OMER

About IMXI International Money Express Inc.

International Money Express Inc is an omnichannel money remittance services company focused on the United States of America to Latin America and the Caribbean corridor, which includes Mexico, Central and South America and the Caribbean. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

About OMER Omeros Corporation

Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. The company's clinical-stage development programs include: narsoplimab, its antibody targeting mannan-binding lectin-associated serine protease 2 (MASP-2), the effector enzyme of the lectin pathway of complement; OMS1029, its long-acting antibody targeting MASP-2; and OMS527, its phosphodiesterase 7 (PDE7) inhibitor program.

Share on Social Networks: